Life Sciences

Insurers Drop GLP-1 Obesity Coverage, Sparking Outrage
Care Insurers Drop GLP-1 Obesity Coverage, Sparking Outrage

What happens when a lifeline for millions of Americans battling obesity is suddenly yanked away by the very systems meant to protect their health? In a nation where over 40% of adults struggle with obesity, GLP-1 receptor agonists—medications like Ozempic and Mounjaro—have emerged as groundbreaking

FDA Launches Pilot for Faster Generic Drug Review in U.S.
Public Policy FDA Launches Pilot for Faster Generic Drug Review in U.S.

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology and manufacturing. With years of experience in the production of diagnostic and treatment devices, Faisal has a unique perspective on the evolving landscape of pharmaceutical

FDA Plans Update to Menopause Hormone Therapy Warnings
Public Policy FDA Plans Update to Menopause Hormone Therapy Warnings

Setting the Stage for Change in Women's Health Imagine millions of women grappling with the debilitating effects of menopause—hot flashes disrupting daily life, night sweats robbing them of sleep, and mood swings straining relationships—yet hesitating to seek relief due to fears of severe hea

How Do Enoby and Xtrenbo Transform Bone Health and Cancer Care?
Public Policy How Do Enoby and Xtrenbo Transform Bone Health and Cancer Care?

Introduction to Biosimilars in Bone Health and Cancer Care Imagine a healthcare landscape where life-altering treatments for bone health and cancer care are out of reach for many due to staggering costs, leaving patients grappling with both disease and financial burden. This scenario is all too

Can Rhapsido Revolutionize Chronic Urticaria Treatment?
Care Can Rhapsido Revolutionize Chronic Urticaria Treatment?

Today, we’re thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology. With a career dedicated to advancing innovation in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique perspective to the table. In this

Mytesi Seeks FDA Orphan Status for Breast Cancer Diarrhea
Public Policy Mytesi Seeks FDA Orphan Status for Breast Cancer Diarrhea

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep focus on medical technology. With years of experience in the development and manufacturing of cutting-edge medical devices, Faisal brings a unique perspective to the evolving landscape of healthcare innovation.

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later